ANN STEFFENS SCLERODERMA RESEARCH FOUNDATION INC

EIN: 811104933 501(c)(3) Medical Research

ALBANY, NY

Total Revenue
$170,019
Total Expenses
$66,430
Total Assets
$154,673
Net Assets
$154,673
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2016
Legal Domicile
NY
Tax Period
2023-01-01 to 2023-12-31

ANN STEFFENS SCLERODERMA RESEARCH FOUNDATION INC, founded in 2016, is a small nonprofit in the Medical Research sector that reported $170K in total revenue in fiscal year 2023. Revenue surged 304% from the prior year, signaling strong growth momentum. The organization ran a surplus of $104K, a strong 61% operating margin.

Mission

TO FUND RESEARCH OF SCLERDERMA.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $170,019
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $170,019

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $6,576
Program Expenses $58,774
Other Expenses $66,430
TOTAL EXPENSES $66,430

Year-over-Year Comparison

2023 2022 Change
Revenue $170,019 $42,136 +3.0%
Expenses $66,430 $84,317 -0.2%
Net Income $103,589 $-42,181 -3.5%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
3
Employees
N/A
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$0
Total Directors
0
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
BRUCE COWAN VICE PRESIDENT 5.00
Officer
$0 $0 $0
AMY GIETZEN SECRETARY 5.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $170,019 $66,430 $154,673 $103,589
2022 $42,136 $84,317 $51,084 $-42,181
2021 $53,829 $53,105 $93,265 $724
2020 $41,331 $13,099 $92,541 $28,232
2019 $69,057 $24,910 $64,309 $44,147
2018 $57,435 $64,109 $20,162 $-6,674
Explore More Nonprofits
→Top 100 Nonprofits in New York →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare ANN STEFFENS SCLERODERMA RESEARCH FOUNDATION INC with other nonprofits in New York and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.